2016, Number 2
Clinical characterization of cirrhotic patients with hypertensive portal gastropathy
Language: Spanish
References: 30
Page: 172-182
PDF size: 112.21 Kb.
ABSTRACT
Introduction: Hypertensive portal gastropathy (HPG) is a complication of portal hypertension of clinical relevance, which appears in patients with liver cirrhosis. Objective: Characterize the different types of hypertensive portal gastropathy (HPG) according to the presence of manifestations of portal hypertension, the state of liver function and the occurrence of digestive bleeding events. Method: A descriptive, cross-sectional study was conducted in 46 patients diagnosed with cirrhosis and endoscopic evidence of portal hypertensive gastropathy (HPG), treated from 2011 to 2013 in the Gastroenterology Department of Dr. Luis Díaz Soto Central Military Hospital. They were classified according to mild or severe form and comparisons were made between both groups. Results: 78.2% of the patients presented mild gastropathy and the most frequent location was the gastric fundus (78.2%). All cases with the severe form were men (p = 0.008). Among those who had severe gastropathy, those with larger diameter of the portal (18.3 mm vs 13.5 mm, p = 0.001) and spleen (137.4 mm vs 130.03 mm, p = 0, 0002), as well as those who also had esophageal varices (100%, p = 0.007), so that acute bleeding was also more frequent among them (60%, p = 0.01). Hematologic factors of portal hypertension or with degrees of liver function, although 63% of patients were found in groups B and C of the Child-Pughs-Turcotte classification. Conclusions: The severe form of hypertensive portal gastropathy (GPH) is the least frequent, but it is accompanied by relevant clinical, humoral and imaging alterations, which require a personalized attention for this type of patients.REFERENCES
Perini RF, Camara PR, Ferraz JG. Pathogenesis of portal hypertensive gastropathy: translating basic research into clinical practice. Nat Clin Pract Gastroenterol & Hepatol [Internet]. 2009 Mar [cited 2015 Mar 11]; 6(3):150-8. Available from: http://www.nature.com/nrgastro/journal/v6/n3/full/ncpgasthep1356.html
Samada Suarez M, Hernandez Perera JC, Ramos Robaina L, Barroso Marquez L, Gonzalez Rapado L, Cepero Valdes M, et al. Factors that predict survival in patients with cirrhosis considered for liver transplantation. Transplant Proc [Internet]. 2008 Nov [cited 2013 Nov 23]; 40(9):2965-7. Available from: https:// www.clinicalkey.com/#!/content/playContent/1-s2.0-S0041134508011883
de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. Journal Hepatol [Internet]. 2000 [cited 2015 Jul 29]; 33(5):846-52. Available from: http://www.journal-of-hepatology.eu/article/S0168- 8278(00)80320-7/fulltext
Fontana RJ, Sanyal AJ, Ghany MG, Bonkovsky HL, Morgan TR, Litman HJ, et al. Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C. Am J Gastroenterol [Internet]. 2011 [cited 2015 May 29]; 106(5):884-93. Available from: http://www.nature.com/ajg/journal/v106/n5/full/ajg2010456a.html
Licks F, Marques C, Zetler C, Martins MI, Marroni CA, Marroni NP. Antioxidant effect of N-acetylcysteine on prehepatic portal hypertensive gastropathy in rats. Ann Hepatol [Internet]. 2014 May-Jun [cited 2016 Jan 06]; 13(3):370-7. Available from: http://www.annalsofhepatology.com/revista/numeros/2014/10_143_v13n3_2014_ AntioxidantEffect.pdf
Abbasi A, Bhutto AR, Butt N, Munir SM, Dhillo AK. Frequency of portal hypertensive gastropathy and its relationship with biochemical, haematological and endoscopic features in cirrhosis. J Coll Physicians Surg Pak [Internet]. 2011 Dec [cited 2015 Nov 26]; 21(12):723-6.]Available from: http://www.jcpsp.pk/archive/2011/Dec2011/02.pdf
Kim MY, Choi H, Baik SK, Yea CJ, Won CS, Byun JW, et al. Portal hypertensive gastropathy: correlation with portal hypertension and prognosis in cirrhosis. Dig Dis Sci.[Internet]. 2010 Dec [cited 2015 Jul 15]; 55(12):3561-7. Available from: http://link.springer.com/article/10.1007/s10620-010-1221-6/fulltext.html
Samada M, Hernández J, Barroso L, Chao L, González M, Fernández I. Identificación de factores de riesgo de presencia de várices esofágicas en pacientes con cirrosis hepática. Rev Cub Med Mil [Internet]. 2008 [citado 06 jun 2015]; 37(1) Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138- 65572008000100002&lng=es
Infante Velázquez M, Fuentes Ramos M, Pérez Lorenzo M, Ramos Contreras Y, Winograd Lay R, Angulo Pérez O. Ligadura endoscópica de várices esofágicas más propranolol para profilaxis secundaria del sangrado digestivo en pacientes cirróticos. Rev Cubana Med Mil [Internet]. 2013 [citado12 jul 2014]; 42:39-48. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138- 65572013000100006&nrm=iso
Lahbabi M, Mellouki I, Aqodad N, Elabkari M, Elyousfi M, SA I, et al. Esophageal variceal ligation in the secondary prevention of variceal bleeding: Result of long term follow-up. Pan Afr Med J [Internet]. 2013 May [cited 2015 Feb 17];15:3-7. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708329